F0U.F NAVCO Pharmaceuticals Inc.
- Market cap
- EUR 57.1K
- P/E
- -
- P/B
- -
- ROE
- -2,698.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Sep 2022.
Is F0U.F undervalued?
Graham numberThe Graham number of NAVCO Pharmaceuticals Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NAVCO Pharmaceuticals Inc. fundamental analysis
No fundamental analysis for NAVCO Pharmaceuticals Inc. yet.
NAVCO Pharmaceuticals Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NAVCO Pharmaceuticals Inc.
NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives indu…
Full company profileNAVCO Pharmaceuticals Inc. financial statements
NAVCO Pharmaceuticals Inc. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 |
|---|---|---|
| Income Statement | ||
| Revenue | 0.00 | 0.00 |
| Operating Income | -79.5K | -100K |
| EBITDA | - | -100K |
| Net Income | -74.1K | -93.7K |
| EPS | -0.02 | -0.02 |
| Balance Sheet | ||
| Total Assets | 116K | 112K |
| Total Liabilities | 18.9K | 109K |
| Shareholders' Equity | 97.2K | 3.47K |
| Cash & Short-term Investments | 12.1K | 1.80K |
| Cash Flow | ||
| Operating Cash Flow | -80.7K | -10.3K |
| Capital Expenditure | 0.00 | 0.00 |
| Free Cash Flow | -80.7K | -10.3K |
| Ratios | ||
| ROE | -76.3% | -2,698.2% |
| ROA | -63.8% | -83.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
NAVCO Pharmaceuticals Inc. dividends
NAVCO Pharmaceuticals Inc. has not paid dividends in the last 2 fiscal years.
Who owns NAVCO Pharmaceuticals Inc.
- Insiders 10.49%
- Institutions 0.00%
- Public & others 89.51%
- Shares outstanding 57.1M
- Free float 51.8M
NAVCO Pharmaceuticals Inc. company profile
- Company name
- NAVCO Pharmaceuticals Inc.
- Ticker
- F0U.F
- ISIN
- CA63942R1091
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Fiscal year end
- September
- Address
- 1170 ? 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1
- Website
- navcopharma.com
About NAVCO Pharmaceuticals Inc.
NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.
NAVCO Pharmaceuticals Inc. management
4- Mr. Geoffrey LeeChief Executive Officer
- Mr. Christopher R. CooperChief Financial Officer · born 1971
- Mr. Marek JasinskiCOO & Director · born 1977
- Mr. Thomas JusdanisCorporate Secretary & Independent Director · born 1958